US Stock MarketDetailed Quotes

BDMD Baird Medical Investment Holdings

Watchlist

1.990
+0.160+8.74%

Trading Dec 23 15:02 ET

71.20MMarket Cap49.75P/E (TTM)

Baird Medical Investment Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

-10.35%31.46M

26.58%35.09M

27.72M

Operating revenue

-10.35%31.46M

26.58%35.09M

--27.72M

Cost of revenue

-40.07%4.23M

55.24%7.05M

4.54M

Gross profit

-2.88%27.23M

20.96%28.04M

23.18M

Operating expense

11.87%14.58M

29.19%13.03M

10.09M

Selling and administrative expenses

5.20%11.09M

3.18%10.55M

--10.22M

-Selling and marketing expense

-28.96%2.55M

0.43%3.59M

--3.57M

-General and administrative expense

22.79%8.55M

4.65%6.96M

--6.65M

Research and development costs

10.77%4.27M

271.08%3.86M

--1.04M

Other operating expenses

42.42%-791.96K

-17.06%-1.38M

---1.18M

Operating profit

-15.68%12.65M

14.63%15.01M

13.09M

Net non-operating interest income expense

2.22%-284.27K

-91.77%-290.72K

-151.6K

Non-operating interest income

-81.74%1.56K

267.71%8.55K

--2.33K

Non-operating interest expense

-4.49%285.83K

94.43%299.27K

--153.92K

Other net income (expense)

94.75%-10.21K

41.93%-194.58K

-335.08K

Other non- operating income (expenses)

94.75%-10.21K

41.93%-194.58K

---335.08K

Income before tax

-14.89%12.36M

15.20%14.52M

12.61M

Income tax

-2.63%1.7M

-27.89%1.75M

2.42M

Net income

-16.57%10.66M

25.45%12.77M

10.18M

Net income continuous Operations

-16.57%10.66M

25.45%12.77M

--10.18M

Minority interest income

-45.59%112.21K

119.47%206.22K

93.97K

Net income attributable to the parent company

-16.09%10.55M

24.58%12.57M

10.09M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-16.09%10.55M

24.58%12.57M

10.09M

Basic earnings per share

-16.09%0.2975

24.58%0.3545

0.2846

Diluted earnings per share

-16.09%0.2975

24.58%0.3545

0.2846

Dividend per share

Currency Unit

USD

USD

USD

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	-10.35%31.46M	26.58%35.09M	27.72M
Operating revenue	-10.35%31.46M	26.58%35.09M	--27.72M
Cost of revenue	-40.07%4.23M	55.24%7.05M	4.54M
Gross profit	-2.88%27.23M	20.96%28.04M	23.18M
Operating expense	11.87%14.58M	29.19%13.03M	10.09M
Selling and administrative expenses	5.20%11.09M	3.18%10.55M	--10.22M
-Selling and marketing expense	-28.96%2.55M	0.43%3.59M	--3.57M
-General and administrative expense	22.79%8.55M	4.65%6.96M	--6.65M
Research and development costs	10.77%4.27M	271.08%3.86M	--1.04M
Other operating expenses	42.42%-791.96K	-17.06%-1.38M	---1.18M
Operating profit	-15.68%12.65M	14.63%15.01M	13.09M
Net non-operating interest income expense	2.22%-284.27K	-91.77%-290.72K	-151.6K
Non-operating interest income	-81.74%1.56K	267.71%8.55K	--2.33K
Non-operating interest expense	-4.49%285.83K	94.43%299.27K	--153.92K
Other net income (expense)	94.75%-10.21K	41.93%-194.58K	-335.08K
Other non- operating income (expenses)	94.75%-10.21K	41.93%-194.58K	---335.08K
Income before tax	-14.89%12.36M	15.20%14.52M	12.61M
Income tax	-2.63%1.7M	-27.89%1.75M	2.42M
Net income	-16.57%10.66M	25.45%12.77M	10.18M
Net income continuous Operations	-16.57%10.66M	25.45%12.77M	--10.18M
Minority interest income	-45.59%112.21K	119.47%206.22K	93.97K
Net income attributable to the parent company	-16.09%10.55M	24.58%12.57M	10.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-16.09%10.55M	24.58%12.57M	10.09M
Basic earnings per share	-16.09%0.2975	24.58%0.3545	0.2846
Diluted earnings per share	-16.09%0.2975	24.58%0.3545	0.2846
Dividend per share
Currency Unit	USD	USD	USD

US

Overall

No Data